It’s long-term, well it’s for life basically: Understanding and exploring the burden of immunoglobulin treatment in patients with primary immunodeficiency disorders
This paper describes the burden of receiving immunoglobulin (Ig) treatment from the perspective of patients diagnosed with a Primary Immunodeficiency (PID). Thirty semi-structured interviews with patients receiving intravenous (n=21) and subcutaneous immunoglobulin (n=9) therapy, either at home or...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2021-02-01
|
Series: | Qualitative Research in Medicine & Healthcare |
Subjects: | |
Online Access: | https://pagepressjournals.org/index.php/qrmh/article/view/9564 |
id |
doaj-db51ca79a1bc4f59b3660e34d70a89dc |
---|---|
record_format |
Article |
spelling |
doaj-db51ca79a1bc4f59b3660e34d70a89dc2021-02-25T21:09:09ZengPAGEPress PublicationsQualitative Research in Medicine & Healthcare2532-20442021-02-014310.4081/qrmh.2020.9564It’s long-term, well it’s for life basically: Understanding and exploring the burden of immunoglobulin treatment in patients with primary immunodeficiency disordersGeorgina Jones0Eva Brown Hajdukova 1Esmee Hanna2Rosie Duncan3Brendan Gough4Jane Hughes5Debbie Hughes6Fran Ashworth7Johan Prevot8Jose Drabwell9Leire Solis10Nizar Mahlaoui11Anna Shrimpton12Department of Psychology, School of Social Sciences, Leeds Beckett University, LeedsParexel Access Consulting, Parexel International, LondonCentre for Health Promotion School of Health and Community Studies, De Montfort University, LeicesterSchool of Health and Related Research, University of Sheffield, SheffieldDepartment of Psychology, School of Social Sciences, Leeds Beckett University, LeedsSchool of Health and Related Research, University of Sheffield, SheffieldClinical Immunology and Allergy Unit, Northern General Hospital, Sheffield Teaching Hospitals and NHS Foundation Trust, SheffieldClinical Immunology and Allergy Unit, Northern General Hospital, Sheffield Teaching Hospitals and NHS Foundation Trust, SheffieldInternational Patient Organisation for Primary Immunodeficiencies, Rocky Bottom, Trerieve, Downderry, CornwallInternational Patient Organisation for Primary Immunodeficiencies, Rocky Bottom, Trerieve, Downderry, CornwallInternational Patient Organisation for Primary Immunodeficiencies, Rocky Bottom, Trerieve, Downderry, CornwallFrench National Reference Center for Primary Immune Deficiencies (CEREDIH), Necker Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Pediatric Immuno-Haematology and Rheumatology Unit, Necker Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris, ParisClinical Immunology and Allergy Unit, Northern General Hospital, Sheffield Teaching Hospitals and NHS Foundation Trust, Sheffield This paper describes the burden of receiving immunoglobulin (Ig) treatment from the perspective of patients diagnosed with a Primary Immunodeficiency (PID). Thirty semi-structured interviews with patients receiving intravenous (n=21) and subcutaneous immunoglobulin (n=9) therapy, either at home or in hospital were undertaken. Underpinned by a phenomenological theoretical framework, and using a qualitative, inductive thematic approach to prioritise patients’ concerns, we identified that Ig treatment requires considerable effort by the patient, particularly in relation to the amount of time, organization and planning that is needed. They also face numerous physical, social, relationship, emotional, role functioning, travelling, and financial challenges in their effort to undergo and maintain their infusions and care for their health. Some qualitative differences in treatment burden were noted between home and hospital settings which contributed to non-adherence to those regimes. Immunoglobulin treatment burden is complex and influenced by therapeutic mode and setting and the personal circumstances of the patient. As choice over treatment method appears to be mainly informed by lifestyle needs, PID patients may benefit from more information about these potential Ig lifestyle influences when selecting which form of treatment to take together with their health professional. https://pagepressjournals.org/index.php/qrmh/article/view/9564Primary immunodeficiencyimmunoglobulin treatmentqualitative researchthematic analysis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Georgina Jones Eva Brown Hajdukova Esmee Hanna Rosie Duncan Brendan Gough Jane Hughes Debbie Hughes Fran Ashworth Johan Prevot Jose Drabwell Leire Solis Nizar Mahlaoui Anna Shrimpton |
spellingShingle |
Georgina Jones Eva Brown Hajdukova Esmee Hanna Rosie Duncan Brendan Gough Jane Hughes Debbie Hughes Fran Ashworth Johan Prevot Jose Drabwell Leire Solis Nizar Mahlaoui Anna Shrimpton It’s long-term, well it’s for life basically: Understanding and exploring the burden of immunoglobulin treatment in patients with primary immunodeficiency disorders Qualitative Research in Medicine & Healthcare Primary immunodeficiency immunoglobulin treatment qualitative research thematic analysis |
author_facet |
Georgina Jones Eva Brown Hajdukova Esmee Hanna Rosie Duncan Brendan Gough Jane Hughes Debbie Hughes Fran Ashworth Johan Prevot Jose Drabwell Leire Solis Nizar Mahlaoui Anna Shrimpton |
author_sort |
Georgina Jones |
title |
It’s long-term, well it’s for life basically: Understanding and exploring the burden of immunoglobulin treatment in patients with primary immunodeficiency disorders |
title_short |
It’s long-term, well it’s for life basically: Understanding and exploring the burden of immunoglobulin treatment in patients with primary immunodeficiency disorders |
title_full |
It’s long-term, well it’s for life basically: Understanding and exploring the burden of immunoglobulin treatment in patients with primary immunodeficiency disorders |
title_fullStr |
It’s long-term, well it’s for life basically: Understanding and exploring the burden of immunoglobulin treatment in patients with primary immunodeficiency disorders |
title_full_unstemmed |
It’s long-term, well it’s for life basically: Understanding and exploring the burden of immunoglobulin treatment in patients with primary immunodeficiency disorders |
title_sort |
it’s long-term, well it’s for life basically: understanding and exploring the burden of immunoglobulin treatment in patients with primary immunodeficiency disorders |
publisher |
PAGEPress Publications |
series |
Qualitative Research in Medicine & Healthcare |
issn |
2532-2044 |
publishDate |
2021-02-01 |
description |
This paper describes the burden of receiving immunoglobulin (Ig) treatment from the perspective of patients diagnosed with a Primary Immunodeficiency (PID). Thirty semi-structured interviews with patients receiving intravenous (n=21) and subcutaneous immunoglobulin (n=9) therapy, either at home or in hospital were undertaken. Underpinned by a phenomenological theoretical framework, and using a qualitative, inductive thematic approach to prioritise patients’ concerns, we identified that Ig treatment requires considerable effort by the patient, particularly in relation to the amount of time, organization and planning that is needed. They also face numerous physical, social, relationship, emotional, role functioning, travelling, and financial challenges in their effort to undergo and maintain their infusions and care for their health. Some qualitative differences in treatment burden were noted between home and hospital settings which contributed to non-adherence to those regimes. Immunoglobulin treatment burden is complex and influenced by therapeutic mode and setting and the personal circumstances of the patient. As choice over treatment method appears to be mainly informed by lifestyle needs, PID patients may benefit from more information about these potential Ig lifestyle influences when selecting which form of treatment to take together with their health professional.
|
topic |
Primary immunodeficiency immunoglobulin treatment qualitative research thematic analysis |
url |
https://pagepressjournals.org/index.php/qrmh/article/view/9564 |
work_keys_str_mv |
AT georginajones itslongtermwellitsforlifebasicallyunderstandingandexploringtheburdenofimmunoglobulintreatmentinpatientswithprimaryimmunodeficiencydisorders AT evabrownhajdukova itslongtermwellitsforlifebasicallyunderstandingandexploringtheburdenofimmunoglobulintreatmentinpatientswithprimaryimmunodeficiencydisorders AT esmeehanna itslongtermwellitsforlifebasicallyunderstandingandexploringtheburdenofimmunoglobulintreatmentinpatientswithprimaryimmunodeficiencydisorders AT rosieduncan itslongtermwellitsforlifebasicallyunderstandingandexploringtheburdenofimmunoglobulintreatmentinpatientswithprimaryimmunodeficiencydisorders AT brendangough itslongtermwellitsforlifebasicallyunderstandingandexploringtheburdenofimmunoglobulintreatmentinpatientswithprimaryimmunodeficiencydisorders AT janehughes itslongtermwellitsforlifebasicallyunderstandingandexploringtheburdenofimmunoglobulintreatmentinpatientswithprimaryimmunodeficiencydisorders AT debbiehughes itslongtermwellitsforlifebasicallyunderstandingandexploringtheburdenofimmunoglobulintreatmentinpatientswithprimaryimmunodeficiencydisorders AT franashworth itslongtermwellitsforlifebasicallyunderstandingandexploringtheburdenofimmunoglobulintreatmentinpatientswithprimaryimmunodeficiencydisorders AT johanprevot itslongtermwellitsforlifebasicallyunderstandingandexploringtheburdenofimmunoglobulintreatmentinpatientswithprimaryimmunodeficiencydisorders AT josedrabwell itslongtermwellitsforlifebasicallyunderstandingandexploringtheburdenofimmunoglobulintreatmentinpatientswithprimaryimmunodeficiencydisorders AT leiresolis itslongtermwellitsforlifebasicallyunderstandingandexploringtheburdenofimmunoglobulintreatmentinpatientswithprimaryimmunodeficiencydisorders AT nizarmahlaoui itslongtermwellitsforlifebasicallyunderstandingandexploringtheburdenofimmunoglobulintreatmentinpatientswithprimaryimmunodeficiencydisorders AT annashrimpton itslongtermwellitsforlifebasicallyunderstandingandexploringtheburdenofimmunoglobulintreatmentinpatientswithprimaryimmunodeficiencydisorders |
_version_ |
1724251012889313280 |